Ginkgo Bioworks raising $100 million, partly to pay for acquisition of Bayer’s Sacramento facilities

Boston-based Ginkgo Bioworks Holdings Inc. said it plans to sell $100 million of its stock in a public offering in order to pay for its acquisition of Bayer assets in California.